Clinical Trials · NCT04163874

Alleviating Carbohydrate Counting for Patients With Type 1 Diabetes Using a Novel Insulin-plus-pramlintide Artificial Pancreas

Phase
N/A
Recruitment status
Completed
Sponsor
McGill University
Enrollment
36
Start date
Feb 2020
Locations
1 site, Canada
Primary endpoint
Each participant's time in target range
View Pramlintide compound reference